SNTI (Senti Biosciences Holdings) OCF Yield %: -114.95 (As of Jul. 12, 2026)


SNTI Senti Biosciences Holdings Inc SNTI
22 GF Score
Price $1.03
! 7 Warning Signs
View Full Analysis

What is Senti Biosciences Holdings OCF Yield %?

Senti Biosciences Holdings SNTI +3.00% 22 OCF Yield % is -114.95 as of Jul. 12, 2026. GuruFocus rates SNTI with a GF Score™ of 22/100. The stock has 7 warning signs investors should review. Among 1,410 Biotechnology companies, Senti Biosciences Holdings ranks worse than 92.13% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Senti Biosciences Holdings's Trailing 12-Month Cash Flow from Operations is $-36.88 Mil, and Market Cap is $32.08 Mil. Therefore, Senti Biosciences Holdings's OCF Yield % for today is -114.95%.

The historical rank and industry rank for Senti Biosciences Holdings's OCF Yield % or its related term are showing as below:

SNTI' s OCF Yield % Range Over the Past 10 Years
Min: -875.78   Med: -228.76   Max: -4.8
Current: -114.95


During the past 6 years, the highest OCF Yield % of Senti Biosciences Holdings was -4.80%. The lowest was -875.78%. And the median was -228.76%.

SNTI's OCF Yield % is ranked worse than
92.13% of 1410 companies
in the Biotechnology industry
Industry Median: -8.26 vs SNTI: -114.95

Senti Biosciences Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Senti Biosciences Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Senti Biosciences Holdings OCF Yield % Related Terms


Senti Biosciences Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for Senti Biosciences Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senti Biosciences Holdings OCF Yield % Chart

Senti Biosciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 -56.17 -173.71 -244.23 -135.28

Senti Biosciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.32 -94.74 -101.93 -85.63 -118.32

SNTI vs ALGS, CRVO, NTRB: OCF Yield % Comparison

For the Biotechnology subindustry, Senti Biosciences Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senti Biosciences Holdings OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Senti Biosciences Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Senti Biosciences Holdings's OCF Yield % falls into.


SNTI
22GF Score
Senti Biosciences Holdings Inc SNTI
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senti Biosciences Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Senti Biosciences Holdings's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-43.444 / 32.11416
=-135.28%

Senti Biosciences Holdings's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-7.481 * 4 / 25.28974
=-118.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -114.95 mean?
Senti Biosciences Holdings (SNTI) has a OCF Yield % of -114.95 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Senti Biosciences Holdings and its competitors. According to the industry distribution chart, Senti Biosciences Holdings ranks #1299 out of 1410 companies in the Biotechnology industry, placing it in the top 92.1%.
Is Senti Biosciences Holdings' OCF Yield % too high?
Senti Biosciences Holdings' current OCF Yield % is -114.95. Based on the distribution chart, Senti Biosciences Holdings ranks #1299 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Senti Biosciences Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Senti Biosciences Holdings' OCF Yield % compare to ALGS and CRVO?
According to the Biotechnology industry distribution chart, Senti Biosciences Holdings ranks #1299 out of 1410 companies for OCF Yield %. This places Senti Biosciences Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Senti Biosciences Holdings and its competitors. Senti Biosciences Holdings's current OCF Yield % is -114.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senti Biosciences Holdings stock overvalued right now?
Senti Biosciences Holdings (SNTI) has a current OCF Yield % of -114.95. The current OCF Yield % is -114.95. Senti Biosciences Holdings' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Senti Biosciences Holdings (SNTI), the current OCF Yield % is -114.95 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senti Biosciences Holdings Business Description

Address 2 Corporate Drive, First Floor, South San Francisco, CA, USA, 94080
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
22GF Score

Get the complete analysis for SNTI

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.03
Price